# Safety and Effectiveness of Artemisinin-based Combination Therapies (ACTs) With Repeated Treatments for Uncomplicated Falciparum Malaria Over a Three-year Period

> **NCT01038063** · PHASE4 · UNKNOWN · sponsor: **Liverpool School of Tropical Medicine** · enrollment: 1200 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artemether-lumefantrine combination

## Key facts

- **NCT ID:** NCT01038063
- **Lead sponsor:** Liverpool School of Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2010-12-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038063, "Safety and Effectiveness of Artemisinin-based Combination Therapies (ACTs) With Repeated Treatments for Uncomplicated Falciparum Malaria Over a Three-year Period". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01038063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*